FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053166992> ?p ?o ?g. }

• W2053166992 endingPage "850" @default.
• W2053166992 startingPage "845" @default.
• W2053166992 abstract "To evaluate the efficacy of cidofovir 1% eyedrops with and without cyclosporin A 1% eyedrops as a treatment of acute adenoviral keratoconjunctivitis (AKC).Randomized, controlled trial.Thirty-four patients with acute adenoviral keratoconjunctivitis of recent onset.Patients were divided into 4 treatment groups: 1) cidofovir four times daily, 2) cidofovir 10 times daily, 3) cidofovir four times daily and cyclosporin A four times daily, and 4) sodium chloride four times daily (control). The diagnosis was confirmed by adenoviral polymerase chain reaction from conjunctival swabs. Duration of treatment was 21 days.Severity of conjunctival injection, conjunctival chemosis, punctate epithelial keratitis during the course of treatment, and presence and severity of corneal subepithelial infiltrates were evaluated by a clinical score. Duration until subjective improvement of symptoms was recorded.The frequency of severe corneal opacities was lower with cidofovir (P = 0.048). Cidofovir was toxic locally to the skin of the eyelids and the conjunctiva in a dose-dependent manner. Symptoms of local toxicity were clinically similar to the signs of the initial viral inflammation. They first appeared 8 to 12 days after beginning of treatment and completely subsided 7 to 28 days after discontinuation of cidofovir. The outcome measures of local inflammation did not differ between the four treatment groups. Cyclosporin A did not alter the course of the infection.Cidofovir lowers the frequency of severe corneal opacities, but its clinical use 4 to 10 times daily at a 1% concentration is limited by local toxicity. Further clinical studies to find an efficacious yet tolerable dosage regimen of cidofovir, possibly using an improved pharmaceutical preparation, are required." @default.
• W2053166992 created "2016-06-24" @default.
• W2053166992 creator A5016541523 @default.
• W2053166992 creator A5035282612 @default.
• W2053166992 creator A5039894563 @default.
• W2053166992 creator A5040662398 @default.
• W2053166992 creator A5052081280 @default.
• W2053166992 creator A5066066577 @default.
• W2053166992 creator A5077773109 @default.
• W2053166992 creator A5082162455 @default.
• W2053166992 creator A5083974777 @default.
• W2053166992 date "2002-05-01" @default.
• W2053166992 modified "2023-10-01" @default.
• W2053166992 title "The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis" @default.
• W2053166992 cites W131437240 @default.
• W2053166992 cites W1602047868 @default.
• W2053166992 cites W1972356042 @default.
• W2053166992 cites W1976647347 @default.
• W2053166992 cites W1991208855 @default.
• W2053166992 cites W1994935178 @default.
• W2053166992 cites W1999943982 @default.
• W2053166992 cites W2001224405 @default.
• W2053166992 cites W2017065434 @default.
• W2053166992 cites W2018865993 @default.
• W2053166992 cites W2029805256 @default.
• W2053166992 cites W2045452082 @default.
• W2053166992 cites W2060031355 @default.
• W2053166992 cites W2065258466 @default.
• W2053166992 cites W2086360721 @default.
• W2053166992 cites W2088991785 @default.
• W2053166992 cites W2132462712 @default.
• W2053166992 cites W2144504916 @default.
• W2053166992 cites W2148700537 @default.
• W2053166992 cites W2262829041 @default.
• W2053166992 doi "https://doi.org/10.1016/s0161-6420(02)00992-2" @default.
• W2053166992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11986086" @default.
• W2053166992 hasPublicationYear "2002" @default.
• W2053166992 type Work @default.
• W2053166992 sameAs 2053166992 @default.
• W2053166992 citedByCount "97" @default.
• W2053166992 countsByYear W20531669922012 @default.
• W2053166992 countsByYear W20531669922013 @default.
• W2053166992 countsByYear W20531669922014 @default.
• W2053166992 countsByYear W20531669922015 @default.
• W2053166992 countsByYear W20531669922016 @default.
• W2053166992 countsByYear W20531669922017 @default.
• W2053166992 countsByYear W20531669922018 @default.
• W2053166992 countsByYear W20531669922019 @default.
• W2053166992 countsByYear W20531669922020 @default.
• W2053166992 countsByYear W20531669922021 @default.
• W2053166992 countsByYear W20531669922022 @default.
• W2053166992 countsByYear W20531669922023 @default.
• W2053166992 crossrefType "journal-article" @default.
• W2053166992 hasAuthorship W2053166992A5016541523 @default.
• W2053166992 hasAuthorship W2053166992A5035282612 @default.
• W2053166992 hasAuthorship W2053166992A5039894563 @default.
• W2053166992 hasAuthorship W2053166992A5040662398 @default.
• W2053166992 hasAuthorship W2053166992A5052081280 @default.
• W2053166992 hasAuthorship W2053166992A5066066577 @default.
• W2053166992 hasAuthorship W2053166992A5077773109 @default.
• W2053166992 hasAuthorship W2053166992A5082162455 @default.
• W2053166992 hasAuthorship W2053166992A5083974777 @default.
• W2053166992 hasConcept C126322002 @default.
• W2053166992 hasConcept C141071460 @default.
• W2053166992 hasConcept C142724271 @default.
• W2053166992 hasConcept C16005928 @default.
• W2053166992 hasConcept C203014093 @default.
• W2053166992 hasConcept C204787440 @default.
• W2053166992 hasConcept C2522874641 @default.
• W2053166992 hasConcept C27081682 @default.
• W2053166992 hasConcept C2775984611 @default.
• W2053166992 hasConcept C2776824251 @default.
• W2053166992 hasConcept C2778064476 @default.
• W2053166992 hasConcept C2779714575 @default.
• W2053166992 hasConcept C29730261 @default.
• W2053166992 hasConcept C42219234 @default.
• W2053166992 hasConcept C71924100 @default.
• W2053166992 hasConcept C90924648 @default.
• W2053166992 hasConceptScore W2053166992C126322002 @default.
• W2053166992 hasConceptScore W2053166992C141071460 @default.
• W2053166992 hasConceptScore W2053166992C142724271 @default.
• W2053166992 hasConceptScore W2053166992C16005928 @default.
• W2053166992 hasConceptScore W2053166992C203014093 @default.
• W2053166992 hasConceptScore W2053166992C204787440 @default.
• W2053166992 hasConceptScore W2053166992C2522874641 @default.
• W2053166992 hasConceptScore W2053166992C27081682 @default.
• W2053166992 hasConceptScore W2053166992C2775984611 @default.
• W2053166992 hasConceptScore W2053166992C2776824251 @default.
• W2053166992 hasConceptScore W2053166992C2778064476 @default.
• W2053166992 hasConceptScore W2053166992C2779714575 @default.
• W2053166992 hasConceptScore W2053166992C29730261 @default.
• W2053166992 hasConceptScore W2053166992C42219234 @default.
• W2053166992 hasConceptScore W2053166992C71924100 @default.
• W2053166992 hasConceptScore W2053166992C90924648 @default.
• W2053166992 hasIssue "5" @default.
• W2053166992 hasLocation W20531669921 @default.
• W2053166992 hasLocation W20531669922 @default.
• W2053166992 hasOpenAccess W2053166992 @default.

• next